TrumpRx Shocker: Huge Cuts Or Hype?

President Trump says his administration just delivered the largest prescription drug price cuts in American history, and the White House has the paperwork to back it up.

Quick Take

The White House announced nine new deals with major drug makers to cut prices under a “most-favored-nation” model tied to what other wealthy countries pay.
Trump says the new TrumpRx.gov website already offers steep discounts on common medications, some cut by hundreds of percent.
Critics, including a Senate Democrat minority report, say hundreds of drug prices actually rose since Trump took office.
Border numbers released alongside the drug announcement show record-low crossings and months of zero parole releases.

Trump Announces New Round of Drug Price Deals

President Trump announced nine new agreements with major pharmaceutical companies in December 2025. The deals require companies to sell medicines at steep discounts through a government-linked website called TrumpRx.gov. The administration says the pricing matches the lowest amounts paid by other developed nations, a system known as most-favored-nation pricing.

Trump has repeated the claim in speech after speech. He told one audience the TrumpRx launch marked “the largest reduction in prescription drug prices in history by many, many times”. In earlier remarks tied to a May 2025 executive order, he said some drug prices would drop “almost immediately by 50 to 80 to 90%”.

Specific Drugs Named as Proof

The administration points to specific examples to back the broader claim. Officials say the weight-loss drug Wegovy will drop from $1,350 a month to a small fraction of that price under the new deals. Pfizer separately agreed to offer many prescription medications at major discounts, plus extra savings for Medicaid patients. Insulin prices for low-income and uninsured patients were set as low as three cents, plus a small fee.

Critics Question How the Numbers Are Measured

Fact-checkers push back on parts of the framing. AFP and PolitiFact both flagged an earlier, similar claim that drug prices had fallen further than any point since 1967, calling it misleading because it relied on one narrow price measure while other data showed increases. A Senate Health, Education, Labor and Pensions Committee minority report from Democrats found that drug companies raised prices on 688 prescription drugs after Trump took office, with a median increase of 5.5 percent.

That gap comes down to how prices get measured. Experts note that list prices, the sticker price before any deal, often move separately from net prices, what a company actually collects after rebates paid to middlemen called pharmacy benefit managers. A price can look like it dropped under one measure while staying flat or rising under another, which is exactly the confusion driving the dispute over Trump’s claims.

Still, the White House fact sheets are official government documents laying out specific, named deals with specific companies, not vague promises. Nine agreements exist on paper, and TrumpRx.gov is a live website Americans can check today. Whether every dollar figure Trump cites in a speech holds up under audit is a fair question, but the deals themselves are real and signed.

Border Numbers Released the Same Week

Trump paired the drug announcement with border security claims, and those numbers carry strong documentation. A House Homeland Security Committee brief said December marked eight straight months of zero parole releases by the U.S. Border Patrol, ending the catch-and-release policy from the Biden years. Earlier committee data showed a 94 percent drop in Southwest border apprehensions compared to the year before.

For a base that spent years demanding lower drug costs and a secured border, these two announcements land together as a single message: promises kept on both fronts. The drug pricing debate will keep drawing scrutiny from fact-checkers over which price measure counts. The border numbers, backed by congressional committee data, face far less dispute.